Latest Breaking News On - Biotechnologies indonesia - Page 7 : comparemela.com

Press release content from PR Newswire. The AP news staff was not involved in its creation. Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia January 19, 2021 GMT SAN FRANCISCO and SUZHOU, China, Jan. 18, 2021 /PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced an agreement with PT Etana Biotechnologies Indonesia (Etana) to out-license BYVASDA® (Bevacizumab Biosimilar)’s development and commercialization rights in Indonesia to Etana. Etana is committed to launch BYVASDA® in the local market. In return, Innovent will receive milestones for development and commercialization as well as double-digit royalties on net sales. The specific financial terms were not disclosed.

China
United-states
Indonesia
Canada
Hong-kong
Suzhou
Jiangsu
Indonesian
America
Adimab-incyte
Nathan-tirtana
Eli-lilly